Satish Kumar M N, Archana M, Dayananda V P, Surekha C, Ramachandraiah R
Department of Anesthesiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.
Anesth Essays Res. 2022 Jan-Mar;16(1):127-132. doi: 10.4103/aer.aer_85_21. Epub 2022 Jul 6.
Ultrasound-guided bilateral superficial cervical plexus block (BSCPB) is a technique described for thyroid surgeries for postoperative analgesia as the surgery can cause severe pain and discomfort. Perineural dexamethasone is known to prolong analgesic duration and reduce postoperative nausea/vomiting.
To assess the efficacy of dexamethasone as an adjuvant to BSCPB with 0.25% bupivacaine on isoflurane consumption, intraoperative hemodynamic parameters, and postoperative analgesia in patients undergoing thyroid surgeries under general anesthesia.
This was a randomized control trial.
Eighty patients were randomized to two equal groups using random number table into Group A with BSCPB receiving 20 mL of 0.25% bupivacaine and Group B with BSCPB receiving 19 mL of 0.25% bupivacaine + injection dexamethasone 4 mg in the preinduction period. Hemodynamic parameters, isoflurane consumption, postoperative visual analog scale (VAS) score, and antiemetic effect over 24 h were compared between two groups.
Microsoft excel data sheet, Chi-square test, and independent -test were used for statistical analysis.
The intraoperative hemodynamic parameters were comparable between the two groups. There was a significant difference in mean VAS score between two groups from 6 h to 20 h postoperatively. The time of rescue analgesic in Group A was 7.09 ± 1.04 min and Group was 13.19 ± 1.46 min with < 0.0001. In Group A, 40% had nausea and 35% had vomiting, and in Group B, 7.5% had nausea and 5% had vomiting.
Preinduction ultrasound-guided BSCPB with bupivacaine and dexamethasone provides longer duration of postoperative analgesia and lesser nausea and vomiting compared to bupivacaine alone.
超声引导下双侧颈浅丛阻滞(BSCPB)是一种用于甲状腺手术术后镇痛的技术,因为该手术会引起严重疼痛和不适。已知神经周围注射地塞米松可延长镇痛时间并减少术后恶心/呕吐。
评估地塞米松作为0.25%布比卡因辅助剂用于全身麻醉下甲状腺手术患者的异氟烷消耗量、术中血流动力学参数和术后镇痛效果。
这是一项随机对照试验。
80例患者使用随机数字表随机分为两组,A组接受20 mL 0.25%布比卡因的BSCPB,B组在诱导期接受19 mL 0.25%布比卡因+4 mg地塞米松注射液的BSCPB。比较两组的血流动力学参数、异氟烷消耗量、术后视觉模拟评分(VAS)以及24小时内的止吐效果。
使用Microsoft excel数据表、卡方检验和独立样本t检验进行统计分析。
两组术中血流动力学参数相当。术后6小时至20小时两组平均VAS评分有显著差异。A组补救镇痛时间为7.09±1.04分钟,B组为13.19±1.46分钟,P<0.0001。A组40%的患者出现恶心,35%的患者出现呕吐,B组7.5%的患者出现恶心,5%的患者出现呕吐。
与单独使用布比卡因相比,诱导前超声引导下使用布比卡因和地塞米松的BSCPB可提供更长时间的术后镇痛,且恶心和呕吐较少。